HK1131064A1 - 用於治療瘤的組合物和方法 - Google Patents

用於治療瘤的組合物和方法

Info

Publication number
HK1131064A1
HK1131064A1 HK09110894.7A HK09110894A HK1131064A1 HK 1131064 A1 HK1131064 A1 HK 1131064A1 HK 09110894 A HK09110894 A HK 09110894A HK 1131064 A1 HK1131064 A1 HK 1131064A1
Authority
HK
Hong Kong
Prior art keywords
neoplasm
compositions
treating
methods
Prior art date
Application number
HK09110894.7A
Other languages
English (en)
Inventor
Robert D Mass
Gregory D Plowman
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of HK1131064A1 publication Critical patent/HK1131064A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK09110894.7A 2006-12-11 2009-11-20 用於治療瘤的組合物和方法 HK1131064A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87446006P 2006-12-11 2006-12-11
PCT/US2007/068300 WO2008073509A2 (en) 2006-12-11 2007-05-04 Compositions and methods for treating a neoplasm

Publications (1)

Publication Number Publication Date
HK1131064A1 true HK1131064A1 (zh) 2010-01-15

Family

ID=38521756

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09110894.7A HK1131064A1 (zh) 2006-12-11 2009-11-20 用於治療瘤的組合物和方法

Country Status (18)

Country Link
US (1) US20100086544A1 (zh)
EP (1) EP2099489B1 (zh)
JP (1) JP2010512407A (zh)
KR (1) KR101320198B1 (zh)
CN (1) CN101547705B (zh)
AU (1) AU2007333565A1 (zh)
BR (1) BRPI0717688A2 (zh)
CA (1) CA2670707A1 (zh)
DK (1) DK2099489T3 (zh)
HK (1) HK1131064A1 (zh)
IL (1) IL198852A (zh)
MX (1) MX2009006202A (zh)
NZ (1) NZ577058A (zh)
RU (1) RU2482877C2 (zh)
SG (1) SG177891A1 (zh)
SI (1) SI2099489T1 (zh)
WO (1) WO2008073509A2 (zh)
ZA (1) ZA200903489B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0717431A2 (pt) * 2006-09-29 2013-11-12 Oncomed Pharm Inc Composições e métodos de diagnóstico e tratamento do câncer
DK2488204T3 (en) 2009-10-16 2016-06-06 Oncomed Pharm Inc Therapeutic combination and use of DLL4 antagonist antibodies and blood pressure lowering agents
US8551479B2 (en) 2010-09-10 2013-10-08 Oncomed Pharmaceuticals, Inc. Methods for treating melanoma
EP2655334B1 (en) 2010-12-22 2018-10-03 Eutropics Pharmaceuticals, Inc. Compositions and methods useful for treating diseases
US8858941B2 (en) 2011-09-23 2014-10-14 Oncomed Pharmaceuticals, Inc. VEGF/DLL4 binding agents and uses thereof
AU2013232208B2 (en) * 2012-03-14 2017-04-27 Indiana University Research And Technology Corporation Compounds and methods for treating leukemia
EP2914961A4 (en) 2012-10-31 2016-04-20 Oncomed Pharm Inc METHODS AND MONITORING A TREATMENT BY AN ANTAGONIST OF DLL4
GB201409471D0 (en) * 2014-05-28 2014-07-09 Euro Celtique Sa Pharmaceutical composition
US20160176962A1 (en) 2014-10-31 2016-06-23 Oncomed Pharmaceuticals, Inc. Combination Therapy For Treatment Of Disease
HUE048534T2 (hu) 2015-07-27 2020-07-28 Chong Kun Dang Pharmaceutical Corp 1,3,4-oxadiazol-szulfamid-származékok hiszton deacetiláz 6 inhibitorként és ezt tartalmazó gyógyszerkészítmény
CN108026056B (zh) 2015-07-27 2021-08-03 株式会社钟根堂 作为组蛋白脱乙酰酶6抑制剂的1,3,4-噁二唑酰胺衍生物化合物及其药物组合物
RU2697665C1 (ru) 2015-07-27 2019-08-16 Чонг Кун Данг Фармасьютикал Корп. Производные 1,3,4-оксадиазолсульфонамида в качестве ингибиторов деацетилазы гистонов 6 и фармацевтическая композиция, содержащая их
BR112018002304B1 (pt) 2015-08-04 2023-12-19 Chong Kun Dang Pharmaceutical Corp Compostos de derivado de 1,3,4-oxadiazol como inibidor de histona desacetilase 6 e a composição farmacêutica que compreende os mesmos
US11339213B2 (en) 2015-09-23 2022-05-24 Mereo Biopharma 5, Inc. Methods and compositions for treatment of cancer
WO2017065473A1 (en) 2015-10-12 2017-04-20 Chong Kun Dang Pharmaceutical Corp. Oxadiazole amine derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same
CN116059318A (zh) 2018-01-26 2023-05-05 加利福尼亚大学董事会 用于使用抗vegf剂治疗血管生成病症的方法和组合物
KR102316234B1 (ko) 2018-07-26 2021-10-22 주식회사 종근당 히스톤 탈아세틸화효소 6 억제제로서의 1,3,4-옥사다이아졸 유도체 화합물 및 이를 포함하는 약제학적 조성물
BR112022010113A2 (pt) 2019-11-25 2022-09-06 Univ California Inibidores de vegf de longa ação para neovascularização intraocular

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6281230B1 (en) * 1996-07-24 2001-08-28 Celgene Corporation Isoindolines, method of use, and pharmaceutical compositions
US5635517B1 (en) * 1996-07-24 1999-06-29 Celgene Corp Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines
SE9704545D0 (sv) * 1997-12-05 1997-12-05 Astra Pharma Prod Novel compounds
US6169106B1 (en) * 1998-04-15 2001-01-02 Boehringer Ingelheim Pharma Kg Indolinones having kinase inhibitory activity
WO2000018734A1 (de) * 1998-09-25 2000-04-06 Boehringer Ingelheim Pharma Kg Neue substituierte indolinone mit inhibierender wirkung auf verschiedene kinasen und cyclin/cdk-komplexe
US6762180B1 (en) * 1999-10-13 2004-07-13 Boehringer Ingelheim Pharma Kg Substituted indolines which inhibit receptor tyrosine kinases
US6638965B2 (en) * 2000-11-01 2003-10-28 Boehringer Ingelheim Pharma Kg Substituted indolinones, preparation thereof and their use as pharmaceutical compositions
US7323479B2 (en) * 2002-05-17 2008-01-29 Celgene Corporation Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline
US7758859B2 (en) * 2003-08-01 2010-07-20 Genentech, Inc. Anti-VEGF antibodies
US20050106667A1 (en) * 2003-08-01 2005-05-19 Genentech, Inc Binding polypeptides with restricted diversity sequences
TWI468417B (zh) * 2007-11-30 2015-01-11 Genentech Inc 抗－ｖｅｇｆ抗體

Also Published As

Publication number Publication date
KR20090087908A (ko) 2009-08-18
EP2099489A2 (en) 2009-09-16
CA2670707A1 (en) 2008-06-19
WO2008073509A3 (en) 2009-01-08
US20100086544A1 (en) 2010-04-08
ZA200903489B (en) 2010-08-25
SG177891A1 (en) 2012-02-28
CN101547705A (zh) 2009-09-30
IL198852A (en) 2013-06-27
EP2099489B1 (en) 2014-05-21
IL198852A0 (en) 2011-08-01
SI2099489T1 (sl) 2014-09-30
MX2009006202A (es) 2009-06-22
AU2007333565A1 (en) 2008-06-19
RU2009126588A (ru) 2011-01-20
WO2008073509A2 (en) 2008-06-19
CN101547705B (zh) 2013-06-12
RU2482877C2 (ru) 2013-05-27
BRPI0717688A2 (pt) 2013-01-22
NZ577058A (en) 2012-04-27
DK2099489T3 (da) 2014-08-18
KR101320198B1 (ko) 2013-10-30
JP2010512407A (ja) 2010-04-22

Similar Documents

Publication Publication Date Title
IL198852A0 (en) Compositions and methods for treating a neoplasm
IL257681A (en) Methods and compositions for the treatment of cancer
EP2010117A4 (en) COMPOSITIONS AND METHODS FOR ADHESION INHIBITION
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
IL193014A0 (en) Methods and compositions for treating schizophrenia
ZA200902860B (en) Compositions and methods for binding sphingosine-1-phosphate
HK1137670A1 (zh) 用於關節固定過程的組合物和方法
ZA200900140B (en) Methods and compositions for treating biofilms
EP2037929A4 (en) COMPOSITIONS AND METHODS FOR REDUCING HYPERLIPIDEMIA
EP2101731A4 (en) PROCESSES AND COMPOSITIONS WITH END OXIFES
IL198310A0 (en) Compositions and method for hair loss prevention
EP2015765A4 (en) METHODS AND COMPOSITIONS FOR TREATING CONDITIONS
IL210097A0 (en) Compositions and methods for treating unfluenza
EP2078522A4 (en) COMPOSITION FOR THE TREATMENT OF ALLERGIES
EP2088865A4 (en) METHODS AND COMPOSITIONS AROUND GUGGULPHOSPHOLIPIDS
EP2057179A4 (en) COMPOSITION AND METHOD FOR THE TREATMENT OF MYELOSUPPRESSION
EP2016706A4 (en) METHOD AND ARRANGEMENT FOR VIRTUAL MEETING
EP2132251A4 (en) COMPOSITION AND METHOD
GB0625208D0 (en) Composition and method
GB0600261D0 (en) Composition and method
EP2094279A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF INFLUENZA
EP2170314A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF PHENYLCETONURIA
GB0607488D0 (en) Composition and process
GB0605004D0 (en) Composition and process
GB0604315D0 (en) Composition and method

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200504